FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2609051756> ?p ?o ?g. }

• W2609051756 endingPage "3151" @default.
• W2609051756 startingPage "3143" @default.
• W2609051756 abstract "West Nile virus (WNV) is the leading cause of domestically-acquired arboviral disease in the United States. Several WNV vaccines are in various stages of development. We estimate the cost-effectiveness of WNV vaccination programs targeting groups at increased risk for severe WNV disease. We used a mathematical model to estimate costs and health outcomes of vaccination with WNV vaccine compared to no vaccination among seven cohorts, spaced at 10 year intervals from ages 10 to 70 years, each followed until 90-years-old. U.S. surveillance data were used to estimate WNV neuroinvasive disease incidence. Data for WNV seroprevalence, acute and long-term care costs of WNV disease patients, quality-adjusted life-years (QALYs), and vaccine characteristics were obtained from published reports. We assumed vaccine efficacy to either last lifelong or for 10 years with booster doses given every 10 years. There was a statistically significant difference in cost-effectiveness ratios across cohorts in both models and all outcomes assessed (Kruskal-Wallis test p < 0.0001). The 60-year-cohort had a mean cost per neuroinvasive disease case prevented of $664,000 and disability averted of $1,421,000 in lifelong model and $882,000 and $1,887,000, respectively in 10-year immunity model; these costs were statistically significantly lower than costs for other cohorts (p < 0.0001). Vaccinating 70-year-olds had the lowest cost per death averted in both models at around $4.7 million (95%CI $2–$8 million). Cost per disease case averted was lowest among 40- and 50-year-old cohorts and cost per QALY saved lowest among 60-year cohorts in lifelong immunity model. The models were most sensitive to disease incidence, vaccine cost, and proportion of persons developing disease among infected. Age-based WNV vaccination program targeting those at higher risk for severe disease is more cost-effective than universal vaccination. Annual variation in WNV disease incidence, QALY weights, and vaccine costs impact the cost effectiveness ratios." @default.
• W2609051756 created "2017-05-05" @default.
• W2609051756 creator A5003805127 @default.
• W2609051756 creator A5024062992 @default.
• W2609051756 creator A5043273698 @default.
• W2609051756 creator A5060038112 @default.
• W2609051756 date "2017-05-01" @default.
• W2609051756 modified "2023-10-11" @default.
• W2609051756 title "Cost effectiveness of a targeted age-based West Nile virus vaccination program" @default.
• W2609051756 cites W1977776729 @default.
• W2609051756 cites W1980534414 @default.
• W2609051756 cites W1988401985 @default.
• W2609051756 cites W2005549185 @default.
• W2609051756 cites W2010305470 @default.
• W2609051756 cites W2011394998 @default.
• W2609051756 cites W2012952426 @default.
• W2609051756 cites W2014210754 @default.
• W2609051756 cites W2016305868 @default.
• W2609051756 cites W2018810796 @default.
• W2609051756 cites W2031761588 @default.
• W2609051756 cites W2033969877 @default.
• W2609051756 cites W2048100334 @default.
• W2609051756 cites W2050104286 @default.
• W2609051756 cites W2061769992 @default.
• W2609051756 cites W2094024668 @default.
• W2609051756 cites W2103474897 @default.
• W2609051756 cites W2105915614 @default.
• W2609051756 cites W2106056357 @default.
• W2609051756 cites W2107771044 @default.
• W2609051756 cites W2111180289 @default.
• W2609051756 cites W2113507178 @default.
• W2609051756 cites W2118449839 @default.
• W2609051756 cites W2119917630 @default.
• W2609051756 cites W2126102284 @default.
• W2609051756 cites W2128793172 @default.
• W2609051756 cites W2129551153 @default.
• W2609051756 cites W2135667642 @default.
• W2609051756 cites W2145745395 @default.
• W2609051756 cites W2147051934 @default.
• W2609051756 cites W2159889994 @default.
• W2609051756 cites W2160780170 @default.
• W2609051756 cites W2165406282 @default.
• W2609051756 cites W2329413583 @default.
• W2609051756 doi "https://doi.org/10.1016/j.vaccine.2016.11.078" @default.
• W2609051756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28456529" @default.
• W2609051756 hasPublicationYear "2017" @default.
• W2609051756 type Work @default.
• W2609051756 sameAs 2609051756 @default.
• W2609051756 citedByCount "17" @default.
• W2609051756 countsByYear W26090517562017 @default.
• W2609051756 countsByYear W26090517562018 @default.
• W2609051756 countsByYear W26090517562019 @default.
• W2609051756 countsByYear W26090517562020 @default.
• W2609051756 countsByYear W26090517562021 @default.
• W2609051756 countsByYear W26090517562022 @default.
• W2609051756 crossrefType "journal-article" @default.
• W2609051756 hasAuthorship W2609051756A5003805127 @default.
• W2609051756 hasAuthorship W2609051756A5024062992 @default.
• W2609051756 hasAuthorship W2609051756A5043273698 @default.
• W2609051756 hasAuthorship W2609051756A5060038112 @default.
• W2609051756 hasBestOaLocation W26090517561 @default.
• W2609051756 hasConcept C112930515 @default.
• W2609051756 hasConcept C120665830 @default.
• W2609051756 hasConcept C121332964 @default.
• W2609051756 hasConcept C126322002 @default.
• W2609051756 hasConcept C144024400 @default.
• W2609051756 hasConcept C149923435 @default.
• W2609051756 hasConcept C159654299 @default.
• W2609051756 hasConcept C187212893 @default.
• W2609051756 hasConcept C203014093 @default.
• W2609051756 hasConcept C22070199 @default.
• W2609051756 hasConcept C2778494684 @default.
• W2609051756 hasConcept C2779134260 @default.
• W2609051756 hasConcept C3019080777 @default.
• W2609051756 hasConcept C45189115 @default.
• W2609051756 hasConcept C61511704 @default.
• W2609051756 hasConcept C64332521 @default.
• W2609051756 hasConcept C71924100 @default.
• W2609051756 hasConcept C72563966 @default.
• W2609051756 hasConceptScore W2609051756C112930515 @default.
• W2609051756 hasConceptScore W2609051756C120665830 @default.
• W2609051756 hasConceptScore W2609051756C121332964 @default.
• W2609051756 hasConceptScore W2609051756C126322002 @default.
• W2609051756 hasConceptScore W2609051756C144024400 @default.
• W2609051756 hasConceptScore W2609051756C149923435 @default.
• W2609051756 hasConceptScore W2609051756C159654299 @default.
• W2609051756 hasConceptScore W2609051756C187212893 @default.
• W2609051756 hasConceptScore W2609051756C203014093 @default.
• W2609051756 hasConceptScore W2609051756C22070199 @default.
• W2609051756 hasConceptScore W2609051756C2778494684 @default.
• W2609051756 hasConceptScore W2609051756C2779134260 @default.
• W2609051756 hasConceptScore W2609051756C3019080777 @default.
• W2609051756 hasConceptScore W2609051756C45189115 @default.
• W2609051756 hasConceptScore W2609051756C61511704 @default.
• W2609051756 hasConceptScore W2609051756C64332521 @default.
• W2609051756 hasConceptScore W2609051756C71924100 @default.
• W2609051756 hasConceptScore W2609051756C72563966 @default.
• W2609051756 hasIssue "23" @default.

• next